Welcome to CDC Stacks | Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011 - 32658 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011
Filetype[PDF - 1.00 MB]


Details:
No Related Documents.
You May Also Like:
  1. Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment
    Personal Author:
    He, Guang Xue; Xie, Yan Guang; Wang, Li Xia; Borgdorff, Martien W.; van der Werf, Marieke J.; Fan, Ji Huan; Yan, Xing Lu; Li, Fa Bin; Zhang, Xue Zhi; Zhao, Yan Lin; van den Hof, Susan;
    Published:
    May 24 2010
    Source:
    PLoS One. 5(5).
    Description:
    Background : In 2004, an anti-tuberculosis (TB) drug resistance survey in Heilongjiang province, China, enrolled 1574 (79%) new and 421 (21%) retreatment patients. Multi-drug resistant (MDR) TB was detected in 7.2% of new and 30.4% of retreatment pat...
    File Type:
  2. Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
    Personal Author:
    Hingley-Wilson, Suzanne M.; Casey, Rosalyn; Connell, David; Bremang, Samuel; Evans, Jason T.; Hawkey, Peter M.; Smith, Grace E.; Jepson, Annette; Philip, Stuart; Kon, Onn Min; Lalvani, Ajit;
    Published:
    Jul 2013
    Source:
    Emerg Infect Dis. 19(7):1138-1141.
    Description:
    Infections with >1 Mycobacterium tuberculosis strain(s) are underrecognized. We show, in vitro and in vivo, how first-line treatment conferred a competitive growth advantage to amplify a multidrug-resistant M. tuberculosis strain in a patient with mi...
    File Type:
    Filetype[PDF - 410.62 KB]
  3. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002–2005
    Personal Author:
    Cavanaugh, J. S.; Kazennyy, B. Y.; Nguyen, M. L.; Kiryanova, E. V.; Vitek, E.; Khorosheva, T. M.; Nemtsova, E.; Cegielski, J. P.;
    Published:
    Jun 11 2012
    Source:
    Int J Tuberc Lung Dis. 16(8):1069-1074.
    Description:
    SETTING : Multidrug-resistant tuberculosis (MDR-TB) treatment facility, Orel Oblast, Russian Federation. : OBJECTIVES : To determine factors associated with poor outcome and to document status of patients after recording of TB outcomes. : DESIGN : Re...
    File Type:
    Filetype[PDF - 278.35 KB]
  4. Multidrug-Resistant Tuberculosis in Europe, 2010–2011
    Personal Author:
    Günther, Gunar; van Leth, Frank; Alexandru, Sofia; Altet, Neus; Avsar, Korkut; Bang, Didi; Barbuta, Raisa; Bothamley, Graham; Ciobanu, Ana; Crudu, Valeriu; Davilovits, Manfred; Dedicoat, Martin; Duarte, Raquel; Gualano, Gina; Kunst, Heinke; de Lange, Wiel; Leimane, Vaira; Magis-Escurra, Cecile; McLaughlin, Anne-Marie; Muylle, Inge; Polcová, Veronika; Pontali, Emanuele; Popa, Christina; Rumetshofer, Rudolf; Skrahina, Alena; Solodovnikova, Varvara; Spinu, Victor; Tiberi, Simon; Viiklepp, Piret; Lange, Christoph;
    Corporate Author:
    TBNET
    Published:
    Mar 2015
    Source:
    Emerg Infect Dis. 21(3):409-416.
    Description:
    Drug-resistant Mycobacterium tuberculosis is challenging elimination of tuberculosis (TB). We evaluated risk factors for TB and levels of second-line drug resistance in M. tuberculosis in patients in Europe with multidrug-resistant (MDR) TB. A total ...
    File Type:
    Filetype[PDF - 495.89 KB]
  5. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
    Personal Author:
    Yuen, Courtney M.; Kurbatova, Ekaterina V.; Tupasi, Thelma; Caoili, Janice Campos; Van Der Walt, Martie; Kvasnovsky, Charlotte; Yagui, Martin; Bayona, Jaime; Contreras, Carmen; Leimane, Vaira; Ershova, Julia; Via, Laura E.; Kim, HeeJin; Akksilp, Somsak; Kazennyy, Boris Y.; Volchenkov, Grigory V.; Jou, Ruwen; Kliiman, Kai; Demikhova, Olga V.; Vasilyeva, Irina A.; Dalton, Tracy; Cegielski, J. Peter;
    Published:
    Dec 29 2015
    Source:
    PLoS Med. 12(12).
    Description:
    Background : For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be effective as well as pyrazinamide. WHO guidelines indicate only mar...
    File Type:
    Filetype[PDF - 528.88 KB]